Digital Camera

Because digital cameras make your memories last a lifetime.

Digital Cameras News...

Digital Cameras News Archive
February 2007
January 2007
December 2006
November 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
October 2004
 

Leading Gastroenterologists to Review Highlights From International Conference on Capsule Endoscopy

10 March 2006

Given Imaging (NASDAQ: GIVN) announcedtoday that it will host a conference call on Tuesday, March 7th at 3pm ETto review the highlights from The Fifth Annual International Conference onCapsule Endoscopy (ICCE) to take place in Boca Raton, FL from March 6th -7th. Dr. Blair Lewis from Mt. Sinai School of Medicine in New York and Dr.Roberto De Franchis, Professor of Medicine at the University of Milan inItaly are co-chairing this year's conference.


The webcast will be moderated by several world-renowned gastroenterologistswho will review key clinical findings as well as the 2006 ICCE ConsensusStatement on guidelines for using capsule endoscopy. The first consensusstatement was published in Endoscopy following last year's ICCE conference.


To participate in the teleconference, please dial 877-704-5391 fifteenminutes before the conference begins. International callers should dial913-312-1301. The call will also be webcast live at www.givenimaging.com. Areplay of the call will be available on the company's website by dialing888-203-1112. International callers should dial 719-457-0820. The replayparticipant code is 2166446.


About ICCE:


Started in 2002, The International Conference on Capsule Endoscopy is themain forum for leading gastroenterologists and key opinion leaders toexchange scientific, clinical and practical information about CapsuleEndoscopy. For more information visit www.2006ICCE.com.


About Given Imaging


Given Imaging is redefining gastrointestinal diagnosis by developing,producing and marketing innovative, patient-friendly products for detectinggastrointestinal disorders. The company is developing a complete line ofPillCam™ video capsules for detecting disorders of the gastrointestinaltract. The company's technology platform is the Given® Diagnostic System,featuring the PillCam video capsule, a disposable, miniature video cameracontained in a capsule, which is ingested by the patient. The PillCam™SB capsule is the only naturally ingested method for direct visualizationof the entire small intestine. It is currently marketed in the UnitedStates and in more than 60 other countries and has benefited more than300,000 patients worldwide. The PillCam™ ESO video capsule, whichprovides visual examination of the esophagus, has been cleared formarketing by the FDA. Additional capsules for visualization of the stomachand colon are under development. Given Imaging's headquarters,manufacturing and R&D facilities are located in Yoqneam, Israel; it hasdirect sales and marketing operations in the United States, Germany andFrance, and local offices in Japan, Spain and Australia. For moreinformation, visit http://www.givenimaging.com.


This press release contains forward-looking statements about Given Imaging,including projections about our business, our future revenues and ourfuture profitability, within the meaning of Section 27A of the SecuritiesAct of 1933 and Section 21E of the Securities Exchange Act of 1934. Forexample, statements in the future tense, words such as "anticipates,""estimates," "expects," "intends," "plans," "believes," and words and termsof similar substance used in connection with any discussion of futureoperating or financial performance identify such forward-lookingstatements. Thoseforward-looking statements are not guarantees of future performance andactual results could differ materially from our current expectations as aresult of numerous factors, including but not limited to the following:changes in regulatory environment, our success in implementing our sales,marketing and manufacturing plan, protection and validity of patents andother intellectual property rights, the impact of currency exchange rates,the effect of competition by other companies, the outcome of futurelitigation, the reimbursement policies for our product from healthcarepayors, quarterly variations in operating results, the possibility of armedconflict or civil or military unrest in Israel and other risks disclosed inour filings with the U.S. Securities Exchange Commission.


For further information contact:


Mark GilreathGiven Imaging Ltd.


Fern Lazar / David CareyLazar Partners Ltd.Phone: 1-866-GIVEN-IREmail ContactEmail Contact


SOURCE:  Given Imaging

Source: marketwire


Author:  
Email:    
Topic:    
Content:

All trademarks and copyrighted information contained herein are the property of their respective owners.


Related Articles


 

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z